Use your browser's back button to choose another title or click here for a New Search.



How to Get the Poster

 Open poster (pdf)

 

Bookmark and Share

Implementing Research in Community Treatment Programs: Findings from a CTN Trial.

Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.

Allan J. Cohen, MA, MFT (Bay Area Addiction Research and Treatment, Inc., PR Node), Dan George, MPH (Matrix Institute on Addictions, PR Node), Camille Langlois (Bay Area Addiction Research and Treatment, Inc., PR Node), Ann Moreno (Bay Area Addiction Research and Treatment, Inc., PR Node), Dara Yomjinda (Matrix Institute on Addictions, PR Node), Cynthia Boubion (Matrix Institute on Addictions, PR Node), Judith Martin, MD (Bay Area Addiction Research and Treatment, Inc., PR Node), Roger Donovick, MD (Matrix Institute on Addictions, PR Node), Christie Thomas, MPH (Friends Research Institute, Inc., PR Node), Albert Hasson, MSW (Integrated Substance Abuse Programs, UCLA, PR Node), Cintia Vimieiro (Bay Area Addiction Research and Treatment, Inc., PR Node), Maureen Hillhouse, PhD (Integrated Substance Abuse Programs, UCLA, PR Node), Walter Ling, MD (Integrated Substance Abuse Programs, UCLA, PR Node).

This poster illustrates the evolution of two community treatment programs (CTPs) in the Pacific Node of the National Drug Abuse Treatment Clinical Trials Network (CTN), and describes organizational experiences in their participation in an ongoing trial: Starting Treatment with Agonist Replacement Therapies (START; CTN-0027), designed to evaluate hepatic safety in opiate-dependent individuals receiving Suboxone (buprenorphine/naloxone) or methadone pharmacotherapy for 24 weeks. The overarching goal of the CTN is to bridge the gap between research and practice, improving the "quality of drug abuse treatment throughout the country using science as the vehicle." The process requires two-way communication and a willingness to adapt and learn, which was well exemplified in the four years of participation by these two CTPs (the Matrix Institute on Addictions and Bay Area Addiction, Research and Treatment, Inc.). The experiences of BAART and Matrix illustrate that conducting pragmatic clinical trials research in community treatment settings is not only possible but necessary to assist adoption of research results among physicians, clinicians, providers, and patients. (Poster, PDF, English, 2010)

Keywords: Adoption of interventions | Buprenorphine/Naloxone | Community health services | CTN platform/ancillary study | Dissemination | Methadone maintenance | Pharmacological therapy | Research participation | Suboxone | College on Problems of Drug Dependence (CPDD) annual meeting, 2010

Document No: 493

Submitted by Allan J. Cohen, MA, MFT, Director of Research and Training, BAART, 6/25/2010.

AUTHORS SEARCH LINK
Boubion, Cynthia search
Cohen, Allan J. search mail
Donovick, Roger search
George, Dan search
Hasson, Albert search mail
Hillhouse, Maureen search mail
Langlois, Camille search
Ling, Walter search mail
Martin, Judith search
Moreno, Ann search
Thomas, Christie search
Vimieiro, Cintia search
Yomjinda, Dara search
PROTOCOLS
NIDA-CTN-0027 search www
PARTICIPATING NODES
Pacific Region (Lead) search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 6/2010 -- http://ctndisseminationlibrary.org/display/493.htm
info@ctndisseminationlibrary.org